argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
585.97
+5.38 (0.93%)
Jun 6, 2025, 4:00 PM - Market closed
argenx SE Employees
argenx SE had 1,599 employees as of December 31, 2024. The number of employees increased by 451 or 39.29% compared to the previous year.
Employees
1,599
Change (1Y)
451
Growth (1Y)
39.29%
Revenue / Employee
$1,652,947
Profits / Employee
$665,482
Market Cap
35.89B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,599 | 451 | 39.29% |
Dec 31, 2023 | 1,148 | 305 | 36.18% |
Dec 31, 2022 | 843 | 193 | 29.69% |
Dec 31, 2021 | 650 | 314 | 93.45% |
Dec 31, 2020 | 336 | 148 | 78.72% |
Dec 31, 2019 | 188 | 83 | 79.05% |
Dec 31, 2018 | 105 | 32 | 43.84% |
Dec 31, 2017 | 73 | 15 | 25.86% |
Dec 31, 2016 | 58 | 17 | 41.46% |
Dec 31, 2015 | 41 | 9 | 28.13% |
Dec 31, 2014 | 32 | 10 | 45.45% |
Dec 31, 2013 | 22 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ARGX News
- 6 days ago - argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 11 days ago - argenx Announces Results of Annual General Meeting of Shareholders - GlobeNewsWire
- 4 weeks ago - Argenx Q1 Earnings: Less Than Perfect Report Gets Punished - Seeking Alpha
- 4 weeks ago - argenx SE (ARGX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - argenx Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - argenx to Present at BofA Securities 2025 Health Care Conference - GlobeNewsWire
- 5 weeks ago - argenx to Report First Quarter 2025 Financial Results and Business Update on May 8, 2025 - GlobeNewsWire
- 6 weeks ago - argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - GlobeNewsWire